Transplant in Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma is the most common type of aggressive lymphoma. Patients that don’t respond to first-line therapy have a poor prognosis. Bone marrow transplant represents an effective and established salvage treatment for those patients, with curative potential. Autologous transplant...
| الحاوية / القاعدة: | Brazilian Journal of Transplantation |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Associação Brasileira de Transplante de Órgãos
2022-06-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://bjt.emnuvens.com.br/revista/article/view/445/467 |
| _version_ | 1851937855823151104 |
|---|---|
| author | Guilherme Duffles Carmino De Souza |
| author_facet | Guilherme Duffles Carmino De Souza |
| author_sort | Guilherme Duffles |
| collection | DOAJ |
| container_title | Brazilian Journal of Transplantation |
| description | Diffuse large B-cell lymphoma is the most common type of aggressive lymphoma. Patients that don’t respond to first-line therapy have a poor prognosis. Bone marrow transplant represents an effective and established salvage treatment for those patients, with curative potential. Autologous transplant uses the patient stem cell for rescue after high-dose myeloablative chemotherapy, while allogenic transplant relies on a different stem cell for a graft-versus-lymphoma effect. With distinct toxicity and capacity to induce remission, those therapies have great value in the management of patients with relapsed and refractory diffuse large B-cell lymphoma. |
| format | Article |
| id | doaj-art-50435cb38ade4e5eb4f2b1ed3d412d76 |
| institution | Directory of Open Access Journals |
| issn | 2764-1589 |
| language | English |
| publishDate | 2022-06-01 |
| publisher | Associação Brasileira de Transplante de Órgãos |
| record_format | Article |
| spelling | doaj-art-50435cb38ade4e5eb4f2b1ed3d412d762025-08-19T21:51:32ZengAssociação Brasileira de Transplante de ÓrgãosBrazilian Journal of Transplantation2764-15892022-06-01252e0422e0422https://doi.org/10.53855/bjt.v25i2.445_enTransplant in Diffuse Large B-Cell LymphomaGuilherme Duffles0Carmino De Souza1 Universidade Estadual de Campinas – Faculdade de Ciências Médicas – Hematology and Hemotherapy Center, Campinas (SP), Brazil. Universidade Estadual de Campinas – Faculdade de Ciências Médicas – Hematology and Hemotherapy Center, Campinas (SP), Brazil.Diffuse large B-cell lymphoma is the most common type of aggressive lymphoma. Patients that don’t respond to first-line therapy have a poor prognosis. Bone marrow transplant represents an effective and established salvage treatment for those patients, with curative potential. Autologous transplant uses the patient stem cell for rescue after high-dose myeloablative chemotherapy, while allogenic transplant relies on a different stem cell for a graft-versus-lymphoma effect. With distinct toxicity and capacity to induce remission, those therapies have great value in the management of patients with relapsed and refractory diffuse large B-cell lymphoma.https://bjt.emnuvens.com.br/revista/article/view/445/467lynphomatransplantationautologousallogenic |
| spellingShingle | Guilherme Duffles Carmino De Souza Transplant in Diffuse Large B-Cell Lymphoma lynphoma transplantation autologous allogenic |
| title | Transplant in Diffuse Large B-Cell Lymphoma |
| title_full | Transplant in Diffuse Large B-Cell Lymphoma |
| title_fullStr | Transplant in Diffuse Large B-Cell Lymphoma |
| title_full_unstemmed | Transplant in Diffuse Large B-Cell Lymphoma |
| title_short | Transplant in Diffuse Large B-Cell Lymphoma |
| title_sort | transplant in diffuse large b cell lymphoma |
| topic | lynphoma transplantation autologous allogenic |
| url | https://bjt.emnuvens.com.br/revista/article/view/445/467 |
| work_keys_str_mv | AT guilhermeduffles transplantindiffuselargebcelllymphoma AT carminodesouza transplantindiffuselargebcelllymphoma |